Moreover, another study (67) found that silencing HDAC2 gene could alleviate the ATM/p53-mediated cell death pathway in osteosarcoma U2OS cells in response to adriamycin, confirming that HDAC2 is involved in the early molecular events of DNA damage response and is a coactivator of p53. This evidence concerns the gene TP53 and osteosarcoma.